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Abstract:   
 
Studies attempting to characterize the membrane translocation of antimicrobial and cell-
penetrating peptides frequently are limited by the resolution of conventional light microscopy. 
This study shows that spheroplasts provide a valuable approach to overcome these limits. 
Spheroplasts produce less ambiguous images and allow for more systematic analyses of 
localization. Data collected with spheroplasts are consistent with studies using normal bacterial 
cells and imply that a particular peptide may not always follow the same mechanism of action.  
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Antimicrobial peptides (AMPs) represent a promising alternative to conventional therapeutics in 
the face of concerns about the rise of antibiotic resistant bacteria in clinical settings (1). 
Traditionally, AMPs were believed to kill bacteria through membrane disruption. While many 
AMPs do induce membrane permeabilization, researchers have identified increasing numbers of 
peptides that function by translocating into bacterial cells and targeting intracellular components 
(2). Thus, it has become increasingly important for researchers to reliably determine whether 
AMPs are able to effectively translocate into bacterial cells (3). Many researchers have turned to 
confocal microscopy in order to assess cell entry (4-11). However, bacterial cells are so small 
that effective imaging is limited by the resolution of conventional light microscopes. For 
example, in order to distinguish whether any observed signal from peptides arises from inside the 
cell versus on the cell membrane, researchers ideally should examine individual focal plane 
images throughout cells. However, if signal on the membrane is sufficiently strong it can 
“contaminate” slices ostensibly taken “inside” the cell, as we have observed in measurements of 
the membrane localized dye di-8-ANEPPS (Fig. 1).  
 
In order to overcome these resolution limits, we have employed bacterial spheroplasts (12-14). 
Spheroplasts are produced by culturing bacteria in the presence of an antibiotic, such as 
cephalexin, that prevents division while still allowing cells to grow. The resulting elongated 
bacterial “snakes” are then exposed to lysozyme, which digests the outer cell wall and produces 
spherical spheroplasts that are typically 2-5 µm in diameter (Supplemental Figure 1). Perhaps 
even more important than larger size, the spherical shape allows one to obtain consistent slices 
regardless of how a spheroplast is oriented during imaging.  
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In order to test the validity of using spheroplasts to assess peptide translocation, we have 
measured the cellular localization of four previously characterized peptides (Table 1). To this 
end, we exposed E. coli spheroplasts to peptides with an N-terminally conjugated FITC label for 
imaging; detailed methods for spheroplast preparation and peptide incubation are provided as 
Supplemental Information. As one set of positive and negative controls, we chose buforin II 
(BF2), arguably the best studied membrane translocating AMP (15), and BF2 with a P11A 
mutation that dramatically decreases the peptide’s ability to enter cells and lipid vesicles (6, 16). 
As an additional non-translocating control we employed magainin 2, a prototypical AMP that 
acts at the cell membrane (16). As in previous studies, BF2 and magainin peptides included 
F10W or F5W variations, respectively, which allow for straightforward quantification without 
significantly altering peptide activity or mechanism. We also considered HipC, a cell-penetrating 
peptide without antibacterial activity that was previously observed to enter E. coli (5).  
 
All four control peptides showed the same behavior in spheroplasts as when studied with normal 
E. coli cells (Fig. 2). Both BF2 and HipC clearly showed entry into the majority of spheroplasts, 
while P11A BF2 and magainin typically co-localized with membrane dye. For all samples, we 
found that the use of a membrane dye made it significantly easier to visually distinguish 
membrane localization from cytosol entry, and no samples showed membrane dye signal 
contamination on image slices taken from the inside of spheroplasts, regardless of dye intensity. 
 
In addition to providing improved confocal images, working with spheroplasts also allows us to 
obtain appreciably more individual images than possible when working with normal cells. While 
the smaller samples of images possible with bacterial cells can allow one to demonstrate 
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qualitative trends, the difficulty of obtaining sufficiently high-quality images makes it infeasible 
to perform more systematic analyses of entry data. However, with spheroplasts we can consider 
the percentage of images showing translocation or membrane localization, providing more 
systematic data (Table 1). Again, these percentages support the previously observed trends for 
membrane entry (5, 6, 16), with BF2 and HipC entering significantly more spheroplasts than 
P11A BF2 and magainin. Interestingly, none of these peptides exclusively exhibit membrane 
localization or membrane translocation behavior. It is possible that spheroplast behavior differs 
from bacterial cells or that the observed heterogeneity was related to the exact time of imaging—
for example, perhaps all spheroplasts would show entry with BF2 if allowed to incubate for a 
longer time. However, our observation could also be consistent with the idea that a given AMP 
may not always follow a single, exclusive mechanism. In fact, there is some evidence for this in 
previous studies, such as measurements that show the “translocating” BF2 peptide does induce 
low levels of membrane permeabilization (17), and that the P11A mutation in BF2 reduces but 
does not eliminate translocation into lipid vesicles (16). It will be interesting for future studies on 
spheroplasts, bacterial cells, and other model systems to further evaluate this possibility.  It is 
also worth noting that it is impossible to know for certain whether a particular spheroplast is 
alive, in the process of dying or dead in our images based on the timeframe between peptide 
incubation and mounting and focusing a slide. While this limitation also occurs for studies with 
normal bacteria, the optical advantages of spheroplasts may make studies looking at the 
timeframe of AMP effect on cells more feasible.  
 
In summary, bacterial spheroplasts provide a promising approach for the effective visualization 
of AMP interactions with bacterial cells. Clearly, there are differences between “normal” 
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bacterial cells and spheroplasts, in particular the lack of the outer cell wall. Researchers will need 
to take care to ensure that the lack of cell wall does not affect the results observed in spheroplast 
experiments for peptides. For example, the cell wall may have a “sieving” effect with some 
larger peptides that would be lost in spheroplasts, requiring additional controls comparing 
spheroplasts and “normal” cells in other assays (18). However, even with these caveats we 
believe spheroplasts provide an excellent model system compared to other alternatives to 
overcome size and shape limitations, such as giant unilamellar vesicles (19-21), as spheroplasts 
preserve a physiological bacterial membrane composition and are viable if returned to growth 
conditions (13, 22). Moreover, although spheroplasts have generally been produced from E. coli, 
protocols can be adjusted to make them from other strains (23). Thus, we believe the use of 
bacterial spheroplasts can be a useful addition to the toolbox of researchers characterizing AMPs 
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Table 1:  Sequences of peptides used in the study and percentages of imaged spheroplasts 
showing translocation and membrane localization for each peptide.  Data for each peptide was 
collected from a minimum of at least two independently prepared batches of spheroplasts 
characterized over a total of at least five separate imaging sessions for each peptide; data for each 
spheroplast batch is given in Supplemental Tables 1-4. 
 








BF2 TRSSRAGLQWPVGRVHRLLRK 67 63 37 
P11A BF2 TRSSRAGLQWAVGRVHRLLRK 101 26 74 
magainin 2 GIGKWLHSAKKFGKAFVGEIMNS 60 18 82 











Figure 1:  Confocal images from a z-stack taken of an E. coli cell incubated with the fluorescent 
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Figure 2:  Confocal images of representative E. coli spheroplasts incubated with FITC labeled 
peptides (BF2, P11A BF2, HipC or magainin 2) and di-8-ANEPPS.  Images from the middle of a 
z-stack of each spheroplast were chosen, and the merged fluorescence of FITC (green) and di-8-
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Supplemental Information for Wei et al. 
 
Materials and Methods 
Preparation of E. coli Spheroplasts 
Spheroplasts were prepared from E. coli strain Top 10 (containing a pET45b plasmid for 
ampicillin resistance) in steps similar to that described in Martinac et al. (1). An overnight 
culture grown (37˚C in shaking incubator, approximately 148 rpm) from one plate-picked colony 
was diluted 1:100 in TSB liquid media in the presence of ampicillin (25 µg/mL) and allowed to 
grow to OD600 of 0.5-0.7. 3 mL of this culture was diluted 1:10 into ampicillin-containing TSB 
media and cephalexin was added to reach a final concentration of 60 μg/ml. The culture was then 
shaken at 37˚C for 2-3 hours until single-cell filaments reached sufficient length observable 
under light microscope at 1000x oil immersion magnification; Martinac et al. noted that 
filaments from 50-150 µm should produce spheroplasts 5-10 µm in diameter (1). 
 
Filaments were harvested by centrifugation at 1500 x g for 4 minutes, and the pellet was rinsed 
without resuspension by gentle addition of 1 mL of 0.8 M sucrose with 1 min incubation at room 
temperature and then re-suspended in 3 mL of 0.8M sucrose after supernatant has been removed 
via pipetting. The following reagents were added in order: 150 μL of 1 M Tris Cl (pH 7.8); 120 
μL of lysozyme (5mg/ml); 30 μL of Dnase I (5mg/ml); and 120 μL of 0.125 M sodium EDTA 
(pH 8.0). This mixture was incubated at room temperature for 6 - 10 minutes to hydrolyze the 
peptidoglycan layer, and spheroplast formation was followed under microscope at 1000x. 1 mL 
of Solution A (20 mM MgCl2, 0.7 M sucrose, 10 mM Tris Cl at pH 7.8) was gradually added 
over a 1 minute period while stirring, and the mixture was incubated for 4 minutes at room 
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temperature. The mixture was layered over two separate 7-mL aliquots of Solution B (10 mM 
MgCl2, 0.8 M sucrose, 10 mM Tris Cl at pH 7.8) previously kept on ice. These mixtures were 
centrifuged for 2 minutes at 1000 x g to collect spheroplasts into a pellet, and the majority of the 
supernatant was removed via pipetting. Spheroplast pellets were re-suspended in about 300 μL of 
remaining liquid.      
 
Confocal Microscopy Imaging of Spheroplasts 
Spheroplasts were either prepared immediately before or thawed from frozen stock at -80˚C and 
diluted 1:2 in 0.8 M sucrose. Spheroplasts frozen for at least 1-2 weeks appeared to provide 
consistent results in these experiments. Diluted spheroplasts were then placed on a poly-L-lysine 
coated glass slide and incubated with equal volume of FITC-labeled peptide (peptide stock 
concentration of 1.1-6.2x10-4M), giving an effective peptide concentration above the MIC for 
BF2, P11A BF2 and magainin 2 (HipC has effectively no antibacterial activity against E. coli). 
Peptides were typically incubated with spheroplasts for 1 minute, although some samples with 
HipC were allowed to incubate for 10-20 minutes. All peptides were synthesized at >95% purity 
by NeoScientific (Cambridge, MA) with a FITC group conjugated at the N-terminus. 1 μL of di-
8-ANEPPS (Biotium, Hayward, CA) membrane dye was also added to membrane labeled 
samples. Spheroplasts were visualized with a Leica TCS SP5 laser scanning confocal microscope 
with excitation at 488 nm by an argon laser at 20% laser power output and 20% transmission and 
emission ranges of 499-532 nm (FITC) and 670-745 nm (di-8-ANEPPS). 8-bit, 512x512 images 
were collected at 63X magnification (Leica Plan-Apochromat oil objective; numerical aperture 
1.40). Composite images were produced by Leica LAS AF software (Buffalo Grove, IL). Z-
stacks composed of slices with 0.04-0.08 μm thickness were evaluated for localization of peptide 
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fluorescence within the spheroplast to prevent bias in the reading of the data. Data for each 
peptide was collected from a minimum of at least two independently prepared batches of 
spheroplasts characterized over a total of at least five separate imaging sessions for each peptide 
(Supplemental Tables 1-4). Data was generally consistent between different batches, although a 
few outliers, particularly one batch incubated with buforin II, emphasizes the need for sufficient 
replication to robustly characterize peptide mechanisms.  
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Supplemental Tables 
 
Table 1:  Percentages of imaged spheroplasts showing translocation and membrane localization 
of buforin II (BF2) for different spheroplast batches  
 
 Batch 1 Batch 2 Batch 3 Batch 4 
% translocating 83 11 78 85 
% membrane 
localized 
17 89 22 15 
n of spheroplasts 
imaged 
6 19 9 33 
 
 
Table 2:  Percentages of imaged spheroplasts showing translocation and membrane localization 
of P11A buforin II (BF2) for different spheroplast batches  
 Batch 1 Batch 2 Batch 3 Batch 4 Batch 5 
% 
translocating 
60 22 42 21 15 
% membrane 
localized 
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Table 3:  Percentages of imaged spheroplasts showing translocation and membrane localization 
of magainin 2 for different spheroplast batches  
 Batch 1 Batch 2 









Table 4:  Percentages of imaged spheroplasts showing translocation and membrane localization 
of HipC for different spheroplast batches  
 Batch 1 Batch 2 Batch 3 Batch 4 
% translocating 71 100 100 100 
% membrane 
localized 
28 0 0 0 
n of spheroplasts 
imaged 
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Supplemental Figures 
 
Supplemental Figure 1:  Representative confocal microscopy images of E. coli at different stages 




  Wei et al.,  19 
 
 
Supplemental Figure 2:  Confocal images of representative E. coli spheroplasts incubated with 
FITC labeled peptides (BF2, P11A BF2, HipC or magainin 2) and di-8-ANEPPS.  The merged 
fluorescence of FITC (green) and di-8-ANEPPS (red) is shown.  Images from three different 
positions in a single z-stack are shown for each peptide; z-positions are given relative to the 
middle image of each stack.  
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